dihexa human clinical trials status Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies First in human trial |

BPC 157 therapy can recover glaucomatous rats, normalize intraocular pressure, maintain retinal integrity, recover pupil function, recover retinal ischemia, and corneal injuries (i.e., maintain transparency after complete corneal abrasion, corneal ulceration, and counteract dry eye after lacrimal gland removal or corneal insensitivity) [2,45,86,111,112,113,114]

~ AlphaMD Most men on testosterone replacement therapy expect the muscle gains to follow almost automatically

doi: 10.1540/jsmr.61.82 60 DudleyACGriffioenAW

Product Purity and Quality Standards Peptides supplied for laboratory and in-vitro research use only

Do I need bacteriostatic water or syringes for Dihexa

For instance, 0.5 mg selected, delivers 0.5 mg BPC157 and 0.5 mg TB500 per dose